Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

HIV type 1 lipopeptide vaccine MeSH Supplementary Concept Data 2025


MeSH Supplementary
HIV type 1 lipopeptide vaccine
Unique ID
C512627
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C512627
Entry Term(s)
anti-HIV type 1 lipopeptide vaccine
Registry Numbers
0
Heading Mapped to
*AIDS Vaccines
*Lipopeptides
Frequency
1
Note
includes 6 lipopeptides (N1-3, G1-2, E); well tolerated and able to induce a specific CD4(+) and CD8(+) T cell responses; in clinical trials phase II 7/2006
Source
AIDS Res Hum Retroviruses 2006 Jul;22(7):684-94
Indexing Information
Vaccines, Subunit
Date of Entry
2006/08/22
Revision Date
2008/07/29
HIV type 1 lipopeptide vaccine Preferred
page delivered in 0.004s